• SPX
  • $5,956.30
  • 0.13 %
  • $7.59
  • DJI
  • $44,206.93
  • 0.77 %
  • $336.57
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,262.08
  • 1.38 %
  • $112.81
  • IXIC
  • $18,967.00
  • -0.03 %
  • -$5.42
Talis Biomedical Corporation (TLIS) Stock Price, News & Analysis

Talis Biomedical Corporation (TLIS) Stock Price, News & Analysis

Currency in USD Disclaimer

$1.69

-$0

(0%)

Day's range
$1.69
Day's range
$1.69
50-day range
$1.56
Day's range
$2.2
  • Country: US
  • ISIN: US87424L2079
52 wk range
$1.37
Day's range
$9.6


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -12.33
  • Piotroski Score 1.00
  • Grade Sell
  • Symbol (TLIS)
  • Company Talis Biomedical Corporation
  • Price $1.69
  • Changes Percentage (0%)
  • Change -$0
  • Day Low $1.69
  • Day High $1.69
  • Year High $9.60

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 11/22/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$31.43
  • Trailing P/E Ratio -0.29
  • Forward P/E Ratio -0.29
  • P/E Growth -0.29
  • Net Income $-62,007,000

Income Statement

Quarterly

Annual

Latest News of TLIS

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Talis Biomedical Corporation Frequently Asked Questions

  • What is the Talis Biomedical Corporation stock price today?

    Today's price of Talis Biomedical Corporation is $1.69 — it has decreased by 0% in the past 24 hours. Watch Talis Biomedical Corporation stock price performance more closely on the chart.

  • Does Talis Biomedical Corporation release reports?

    Yes, you can track Talis Biomedical Corporation's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Talis Biomedical Corporation stock forecast?

    Watch the Talis Biomedical Corporation chart and read a more detailed Talis Biomedical Corporation stock forecast to see what analysts suggest you do with its shares.

  • What is Talis Biomedical Corporation stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Talis Biomedical Corporation stock ticker.

  • How to buy Talis Biomedical Corporation stocks?

    Like other stocks, TLIS shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Talis Biomedical Corporation's EBITDA?

    Talis Biomedical Corporation measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Talis Biomedical Corporation’s financial statements.

  • What is the Talis Biomedical Corporation's net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -150.5024271845, which equates to approximately -15,050.24%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Talis Biomedical Corporation stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Talis Biomedical Corporation's financials relevant news, and technical analysis. Talis Biomedical Corporation's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Talis Biomedical Corporation stock currently indicates a “sell” signal. For more insights, review Talis Biomedical Corporation’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.